- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
AI and genome sequencing open up new microbiome treatments
Technology is starting to make it possible to understand the complex interactions of the microbiome in more detail.
Apr 21, 2023Could a “smart toilet” solve the microbiome industry’s data problem?
BiomeSense, a University of Chicago spin out, wants to create a 10m record dataset for the microbiome sector.
Apr 21, 2023Market overview: Microbiome investment grows from a low base
Sometimes called the “last organ under active research”, the human microbiome and therapeutics relating to it are attracting dollars and interest in the innovation community – albeit still from a low base.
Apr 21, 2023Standard Metrics wants to automate the way investors track startup financials
Previous attempts to create financial reporting tech for startups have faltered, but is now the right time for this Slack-backed platform to try again?
Apr 21, 2023Griffis moves up at ADM Ventures
The corporate VC arm invests in startups working at the intersection of food, agriculture, health and sustainability.
Apr 20, 2023Hinz promoted to MD of Global Venture Lab
Niterra Group has promoted Daniel Hinz to managing director for its corporate venturing subsidiary, Global Venture Lab.
Apr 20, 202310 spinouts to watch: April 2023
A treatment for all lung diseases, a rose petal-inspired coating to make solar cells more efficient and a device to resuscitate newborns are among this month's picks.
Apr 20, 2023Data centres turn to photonics to cope with the demands of AI
Data centres need a revamp to allow for the high-speed data processing artificial intelligence requires — and light is key to the transition.
Apr 20, 2023Hitachi raises new $300m AI and Web3-focused fund
Hitachi's third startup investment fund doubles its firepower to $600m. The team is looking to invest in Series A to C rounds.
Apr 20, 2023SR One brings in other drug company investors to join GSK
GSK remains an investor in the new $600m Fund II, but with a smaller financial presence as SR One positions itself to connect startups to multiple companies across the pharmaceuticals sector.
Apr 18, 2023The Big Deal: Pickup pockets $40m as coffee penetrates Southeast Asia
The Go-Ventures led series A comes after Pickup Coffee opened more than 60 locations in the Philippines in its first year, bringing together localisation and tech to fuel rapid growth.
Apr 14, 2023EVs trump driver assistance tech in auto sector's future
Investors are prioritising vehicle electrification over advanced driver-assistance technology as countries rush to adopt EV targets, according to Denso's Tony Cannestra.
Apr 14, 2023Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


